PE130999A1 - 4-oxo-naftiridin-3-carboxamidas sustituidas; ligandos de receptor cerebral gaba - Google Patents

4-oxo-naftiridin-3-carboxamidas sustituidas; ligandos de receptor cerebral gaba

Info

Publication number
PE130999A1
PE130999A1 PE1998001100A PE00110098A PE130999A1 PE 130999 A1 PE130999 A1 PE 130999A1 PE 1998001100 A PE1998001100 A PE 1998001100A PE 00110098 A PE00110098 A PE 00110098A PE 130999 A1 PE130999 A1 PE 130999A1
Authority
PE
Peru
Prior art keywords
alkyl
naftiridin
oxo
cycloalkyl
leaguards
Prior art date
Application number
PE1998001100A
Other languages
English (en)
Spanish (es)
Inventor
Pamela Albaugh
Robert W Desimone
Gang Liu
Original Assignee
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp filed Critical Neurogen Corp
Publication of PE130999A1 publication Critical patent/PE130999A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PE1998001100A 1997-08-25 1998-11-13 4-oxo-naftiridin-3-carboxamidas sustituidas; ligandos de receptor cerebral gaba PE130999A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91818097A 1997-08-25 1997-08-25

Publications (1)

Publication Number Publication Date
PE130999A1 true PE130999A1 (es) 1999-12-16

Family

ID=25439933

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998001100A PE130999A1 (es) 1997-08-25 1998-11-13 4-oxo-naftiridin-3-carboxamidas sustituidas; ligandos de receptor cerebral gaba

Country Status (24)

Country Link
EP (1) EP1007526A1 (lv)
JP (1) JP2001514181A (lv)
KR (1) KR20010023313A (lv)
CN (1) CN1268136A (lv)
AP (1) AP2000001742A0 (lv)
AU (1) AU753800B2 (lv)
BG (1) BG104192A (lv)
BR (1) BR9811362A (lv)
CA (1) CA2301599C (lv)
EG (1) EG21717A (lv)
HU (1) HUP0003258A3 (lv)
IL (1) IL134291A0 (lv)
IS (1) IS5382A (lv)
LV (1) LV12539B (lv)
NO (1) NO20000822L (lv)
NZ (1) NZ502548A (lv)
OA (1) OA11293A (lv)
PE (1) PE130999A1 (lv)
PL (1) PL338783A1 (lv)
SI (1) SI20270A (lv)
SK (1) SK2162000A3 (lv)
TW (1) TW574221B (lv)
WO (1) WO1999010347A1 (lv)
YU (1) YU10500A (lv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0010308A (pt) * 1999-05-06 2002-01-08 Neurogen Corp Composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento de uma doença ou distúrbio associados com o agonismo patogênico, agonismo inverso ou antagonismo do receptor de gabaa, para localizar receptores de gabaa em uma amostra de tecido, para inibir a ligação de um composto de benzodiazepina a um receptor de gabaa e para alterar a atividade da transdução de sinal dos receptores de gabaa, e, composição farmacêutica embalada
US6448246B1 (en) 1999-05-25 2002-09-10 Neurogen Corporation Substituted 4H-1,4-benzothiazine-2-carboxamide: GABA brain receptor ligands
US6730682B2 (en) 2000-07-12 2004-05-04 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
US6559145B2 (en) 2000-07-12 2003-05-06 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
US6562822B2 (en) 2000-07-12 2003-05-13 Pharmacia & Upjohn Company Heterocyle carboxamides as antiviral agents
CZ20031028A3 (cs) 2000-10-12 2003-08-13 Merck & Co., Inc. Aza- a polyazanaftalenylkarboxamidy
WO2002055079A2 (en) 2000-10-12 2002-07-18 Merck & Co Inc Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
DE60128936T2 (de) 2000-10-12 2008-04-10 Merck & Co, Inc. Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer
US20020151591A1 (en) * 2000-10-17 2002-10-17 Anabella Villalobos Combination use of acetylcholinesterase inhibitors and GABAa inverse agonists for the treatment of cognitive disorders
KR20030076717A (ko) * 2001-03-01 2003-09-26 화이자 프로덕츠 인크. 인지 장애의 치료를 위한 니코틴 수용체 부분 아고니스트,에스트로겐, 선택적 에스트로겐 조정자 또는 비타민 ｅ와함께, ｇａｂａａ 역아고니스트의 용도
AR036256A1 (es) 2001-08-17 2004-08-25 Merck & Co Inc Sal sodica de un inhibidor de integrasa del vih, procesos para su preparacion, composiciones farmaceuticas que lo contienen y su uso para la manufactura de un medicamento
ES2291642T3 (es) 2002-01-17 2008-03-01 MERCK & CO., INC. Hidroxinaftiridinoncarboxamidas utiles como inhibidores de la integrasa de vih.
JP4494020B2 (ja) 2002-03-15 2010-06-30 メルク・シャープ・エンド・ドーム・コーポレイション Ｈｉｖインテグラーゼ阻害剤として有用なｎ−（置換ベンジル）−８−ヒドロキシ−１，６−ナフチリジン−７−カルボキサミド
WO2004106336A1 (en) * 2003-05-27 2004-12-09 Pfizer Products Inc. Process for the preparation and purification of 1,5-naphthyridine-3-carboxyamides
WO2004106334A2 (en) * 2003-05-28 2004-12-09 Pfizer Products Inc. Process for the preparation of 1,5-naphthyridine-3-carboxy amides by direct ester amidation
DK2074123T3 (da) * 2006-10-16 2013-01-14 Bionomics Ltd Nye anxiolytiske forbindelser
EP2578216A1 (en) * 2006-11-22 2013-04-10 Seaside Therapeutics, Inc. Methods of treating fragile x syndrome

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR204162A1 (es) * 1972-05-08 1975-11-28 Yamanouchi Pharma Co Ltd Proceso para la preparacion de derivados de ampicilina
GB1433774A (en) * 1973-02-26 1976-04-28 Allen & Hanburys Ltd Heterocyclic compounds apparatus for conveying articles
US4374138A (en) * 1981-11-13 1983-02-15 Warner-Lambert Company Antibacterial amide compounds, compositions, and methods of use
DD295360A5 (de) * 1987-07-03 1991-10-31 Akad Wissenschaften Verfahren zur Herstellung von aktivierten Carbonsäureestern
DD279887A1 (de) * 1987-07-03 1990-06-20 Inst Pharmakologische Forschun Verfahren zur herstellung von d-alpha-(4(1h)-1,5-naphthyridon-3-carboxamido)-benzylpenicillin und anderen beta-lactamantibiotika
DD279875A1 (de) * 1987-07-03 1990-06-20 Inst Pharmakologische Forschun Verfahren zur herstellung von aktivierten carbonsaeureestern
JPS6461461A (en) * 1987-09-01 1989-03-08 Otsuka Pharma Co Ltd Benzohetero ring derivative

Also Published As

Publication number Publication date
IL134291A0 (en) 2001-04-30
BR9811362A (pt) 2000-08-22
OA11293A (en) 2002-11-19
AP2000001742A0 (en) 2000-02-24
NO20000822D0 (no) 2000-02-18
HUP0003258A2 (en) 2001-03-28
AU9117398A (en) 1999-03-16
BG104192A (en) 2001-05-31
PL338783A1 (en) 2000-11-20
LV12539B (lv) 2001-01-20
WO1999010347A1 (en) 1999-03-04
AU753800B2 (en) 2002-10-31
SI20270A (sl) 2000-12-31
LV12539A (en) 2000-10-20
JP2001514181A (ja) 2001-09-11
CA2301599A1 (en) 1999-03-04
CA2301599C (en) 2003-03-25
EG21717A (en) 2002-02-27
YU10500A (sh) 2002-10-18
CN1268136A (zh) 2000-09-27
KR20010023313A (ko) 2001-03-26
TW574221B (en) 2004-02-01
IS5382A (is) 2000-02-22
NZ502548A (en) 2002-06-28
NO20000822L (no) 2000-04-13
SK2162000A3 (en) 2001-03-12
EP1007526A1 (en) 2000-06-14
HUP0003258A3 (en) 2001-05-28

Similar Documents

Publication Publication Date Title
PE130999A1 (es) 4-oxo-naftiridin-3-carboxamidas sustituidas; ligandos de receptor cerebral gaba
DK0613458T3 (da) Acykliske ethylendiaminderivater som substans P receptorantagonister
PE91798A1 (es) Pirrolicarboxanilidas condensadas: utiles como ligandos receptores
AR062299A1 (es) Derivados de bencimidazol
DK0641328T3 (da) Broforbundne, azabicykliske derivater som substans P-antagonister
MX9702601A (es) AGONISTAS beta-ADRENERGICOS HETEROCICLICOS.
PE46899A1 (es) Derivados de n-fenil-sulfonamida
PE109598A1 (es) Pirrolcarboxamidas condensadas, utiles como ligandos de receptores cerebrales gaba
PE20020917A1 (es) Derivados de imidazol como bloqueadores del receptor n-metil-d-aspartato
ES2059327T3 (es) Derivados de tetrahidronaftaleno y de indano, obtencion de los mismos y utilizacion en preparados farmaceuticos.
PE20030417A1 (es) Derivados de urea como antagonistas del receptor vainilloide
RU2004126613A (ru) Замещенные индолы в качестве агонистов альфа-1
HUP0000079A2 (hu) Indán- és dihidroindolszármazékok
PE20010205A1 (es) Derivados 3-sustituido de 2-carboxiciclopropil glicina como agonistas de glutamato
ATE428694T1 (de) N-ä1h-indol-5-ylünaphthalin-1-sulphonamid- derivate und verwandte verbindungen als serotonin 5-ht6 rezeptor antagonisten zur behandlung von erkrankungen des zentralen nervensystems
PE20060457A1 (es) Derivados de difenil eter como antagonistas de los receptores 5ht2
ATE247639T1 (de) Arylsubstituierte cyclische amine als selektive dopamin-d3-liganden
RU2004139099A (ru) 1-(аминоалкил)-3-сульфонилиндольные и -индазольные производные в качестве лигандов 5-гидрокситриптамина-6
ES2130135T3 (es) Nuevos compuestos heterociclicos de 6,7,8,9-tetrahidro-3h-benz(e)indol con actividad terapeutica sobre el sistema nervioso central.
RU2006105782A (ru) Производные 1-сульфонилиндола, их получение и их применение в качестве лигандов 5-нт-6
HUP0001165A2 (hu) NK1 és NK2 antagonista hatású acil-amino-alkil-amid-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra
PE20021018A1 (es) DERIVADOS DE ß - CARBOLINA
PE20000548A1 (es) Derivados de diaza-espiro[3.5]nonano
DE69912419D1 (de) Phenylsulfonamid-phenylethylamine nützlich als dopamin-rezeptoren
PE20020411A1 (es) Compuestos derivados de la triptamina y sus analogos que interactuan con el sistema melatoninergico

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed